CHEMICAL-STABILITY OF N-TRIFLUOROACETYLDOXORUBICIN-14-VALERATE (AD-32) IN AQUEOUS-MEDIA AND AFTER LIPOSOME ENCAPSULATION

被引：5

作者：

BEKERS, O

BEIJNEN, JH

STORM, G

BULT, A

UNDERBERG, WJM

机构：

[1] STATE UNIV UTRECHT,FAC PHARM,DEPT PHARMACEUT ANAL,CATHARIJNESINGEL 60,3511 GH UTRECHT,NETHERLANDS

[2] SLOTERVAART HOSP,NETHERLANDS CANC INST,AMSTERDAM,NETHERLANDS

[3] STATE UNIV UTRECHT,FAC PHARM,DEPT PHARMACEUT,UTRECHT,NETHERLANDS

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1989年 / 56卷 / 02期

关键词：

D O I：

10.1016/0378-5173(89)90002-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：103 / 109

页数：7

共 15 条

[1]

Arcamone F., 1981, DOXORUBICIN ANTICANC

[2] QUANTITATIVE THIN-LAYER CHROMATOGRAPHIC MEASUREMENT OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD-32) AND TRIFLUOROACETYLADRIAMYCIN (AD-41) IN BLOOD AND TISSUES [J].

BARBIERI, B ;

ABBRUZZI, R ;

BENIGNI, A ;

RIZZARDINI, M ;

DONELLI, MG ;

GARATTINI, S ;

SALMONA, M .

JOURNAL OF CHROMATOGRAPHY, 1979, 163 (02) :195-200

[3] ASPECTS OF THE CHEMICAL-STABILITY OF DOXORUBICIN AND 7 OTHER ANTHRACYCLINES IN ACIDIC SOLUTION [J].

BEIJNEN, JH ;

WIESE, G ;

UNDERBERG, WJM .

PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (03) :109-116

[4] STRUCTURE ELUCIDATION AND CHARACTERIZATION OF DAUNORUBICIN DEGRADATION PRODUCTS [J].

BEIJNEN, JH ;

POTMAN, RP ;

VANOOIJEN, RD ;

DRIEBERGEN, RJ ;

VOSKUILEN, MCH ;

RENEMA, J ;

UNDERBERG, WJM .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 34 (03) :247-257

[5] ASPECTS OF THE DEGRADATION KINETICS OF DOXORUBICIN IN AQUEOUS-SOLUTION [J].

BEIJNEN, JH ;

VANDERHOUWEN, OAGJ ;

UNDERBERG, WJM .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 32 (2-3) :123-131

[6]

CROOKE ST, 1981, CANCER CHEMOTHERAPY, V3, P111

[7]

HENDERSON IC, 1978, P AM ASSOC CANC RES, V19, P158

[8]

ISRAEL M, 1975, CANCER RES, V35, P1365

[9]

ISRAEL M, 1978, J PHARMACOL EXP THER, V204, P696

[10]

ISRAEL M, 1980, ANTHRACYCLINES CURRE, P431

← 1 2 →